ILF/CIPHER Webinar: Report back from PADO 3
28 February 2017
The ILF and CIPHER, in collaboration with WHO, held a webinar to disseminate the main outcomes from the Paediatric ARV Drug Optimization (PADO) 3 meeting - which took place during the Geneva Paediatrics Week. The webinar also included an update from the Paediatric ARV Working Group (PAWG).
The objectives of the PADO 3 meeting were as follows:
- Review medium- and long-term priorities for the development of new paediatric ARV drugs and formulations for paediatric HIV treatment and prevention
- Identify research gaps to be addressed and inform optimal use of ARVs in infants, children and adolescents to enable future development and uptake of priority products
- Identify synergies and promote alignment with drug and formulation development for other anti-infective agents to be used in paediatric hepatitis and tuberculosis.
This webinar followed from another webinar to report back from the paediatric week which the ILF and CIPHER held in December 2016 (watch the recording here).